170 related articles for article (PubMed ID: 33985397)
1. Development of 3-methyl/3-(morpholinomethyl)benzofuran derivatives as novel antitumor agents towards non-small cell lung cancer cells.
Al-Sanea MM; Al-Ansary GH; Elsayed ZM; Maklad RM; Elkaeed EB; Abdelgawad MA; Bukhari SNA; Abdel-Aziz MM; Suliman H; Eldehna WM
J Enzyme Inhib Med Chem; 2021 Dec; 36(1):987-999. PubMed ID: 33985397
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and antiproliferative activity of benzofuran-based analogs of cercosporamide against non-small cell lung cancer cell lines.
Bazin MA; Bodero L; Tomasoni C; Rousseau B; Roussakis C; Marchand P
Eur J Med Chem; 2013 Nov; 69():823-32. PubMed ID: 24121233
[TBL] [Abstract][Full Text] [Related]
3. Novel oxindole/benzofuran hybrids as potential dual CDK2/GSK-3β inhibitors targeting breast cancer: design, synthesis, biological evaluation, and
Eldehna WM; Al-Rashood ST; Al-Warhi T; Eskandrani RO; Alharbi A; El Kerdawy AM
J Enzyme Inhib Med Chem; 2021 Dec; 36(1):270-285. PubMed ID: 33327806
[TBL] [Abstract][Full Text] [Related]
4. Novel benzofuran-based sulphonamides as selective carbonic anhydrases IX and XII inhibitors: synthesis and
Abdelrahman MA; Eldehna WM; Nocentini A; Ibrahim HS; Almahli H; Abdel-Aziz HA; Abou-Seri SM; Supuran CT
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):298-305. PubMed ID: 31809607
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and cytotoxic activity against a non-small-cell bronchopulmonary carcinoma line (NSCLC-N6) of benzofuran enantiomeric derivatives.
Hélesbeux JJ; Duval O; Séraphin D; Roussakis C; Richomme P
J Enzyme Inhib Med Chem; 2003 Apr; 18(2):159-65. PubMed ID: 12943200
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, anticancer and antimicrobial evaluation of new benzofuran based derivatives: PI3K inhibition, quorum sensing and molecular modeling study.
El-Khouly OA; Henen MA; El-Sayed MA; Shabaan MI; El-Messery SM
Bioorg Med Chem; 2021 Feb; 31():115976. PubMed ID: 33388654
[TBL] [Abstract][Full Text] [Related]
7. Asperfuranone from Aspergillus nidulans inhibits proliferation of human non-small cell lung cancer A549 cells via blocking cell cycle progression and inducing apoptosis.
Wang CC; Chiang YM; Praseuth MB; Kuo PL; Liang HL; Hsu YL
Basic Clin Pharmacol Toxicol; 2010 Jul; 107(1):583-9. PubMed ID: 20148857
[TBL] [Abstract][Full Text] [Related]
8. Novel Benzo[B]Furans with Anti-Microtubule Activity Upregulate Expression of Apoptotic Genes and Arrest Leukemia Cells in G2/M Phase.
Królewska-Golińska K; Cieślak MJ; Sobczak M; Dolot R; Radzikowska-Cieciura E; Napiórkowska M; Wybrańska I; Nawrot B
Anticancer Agents Med Chem; 2019; 19(3):375-388. PubMed ID: 30465514
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis, biological evaluation and molecular docking studies of novel benzofuran-pyrazole derivatives as anticancer agents.
Abd El-Karim SS; Anwar MM; Mohamed NA; Nasr T; Elseginy SA
Bioorg Chem; 2015 Dec; 63():1-12. PubMed ID: 26368040
[TBL] [Abstract][Full Text] [Related]
10. Design, Synthesis, and Biological Evaluation of Novel Benzofuran Derivatives Bearing N-Aryl Piperazine Moiety.
Ma Y; Zheng X; Gao H; Wan C; Rao G; Mao Z
Molecules; 2016 Dec; 21(12):. PubMed ID: 27941680
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of sulfonate and sulfamate derivatives possessing benzofuran or benzothiophene nucleus as inhibitors of nucleotide pyrophosphatases/phosphodiesterases and anticancer agents.
Anbar HS; El-Gamal R; Ullah S; Zaraei SO; Al-Rashida M; Zaib S; Pelletier J; Sévigny J; Iqbal J; El-Gamal MI
Bioorg Chem; 2020 Nov; 104():104305. PubMed ID: 33017718
[TBL] [Abstract][Full Text] [Related]
12. Benzofuran derivatives as anticancer inhibitors of mTOR signaling.
Salomé C; Ribeiro N; Chavagnan T; Thuaud F; Serova M; de Gramont A; Faivre S; Raymond E; Désaubry L
Eur J Med Chem; 2014 Jun; 81():181-91. PubMed ID: 24836070
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and biological evaluation of novel benzofuran derivatives as potent LSD1 inhibitors.
Zhang X; Huang H; Zhang Z; Yan J; Wu T; Yin W; Sun Y; Wang X; Gu Y; Zhao D; Cheng M
Eur J Med Chem; 2021 Aug; 220():113501. PubMed ID: 33945992
[TBL] [Abstract][Full Text] [Related]
14. Development of novel benzofuran-isatin conjugates as potential antiproliferative agents with apoptosis inducing mechanism in Colon cancer.
Eldehna WM; Salem R; Elsayed ZM; Al-Warhi T; Knany HR; Ayyad RR; Traiki TB; Abdulla MH; Ahmad R; Abdel-Aziz HA; El-Haggar R
J Enzyme Inhib Med Chem; 2021 Dec; 36(1):1424-1435. PubMed ID: 34176414
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and anti-cancer activity evaluation of new aurone derivatives.
Demirayak S; Yurttas L; Gundogdu-Karaburun N; Karaburun AC; Kayagil I
J Enzyme Inhib Med Chem; 2015; 30(5):816-25. PubMed ID: 25716125
[TBL] [Abstract][Full Text] [Related]
16. Ultrasound Assisted Synthesis of 2-Substituted Benzofurans via One-Pot and Sequential Method: Their In Vitro Evaluation.
Rao BVD; Vardhini SV; Kolli D; Rao MVB; Pal M
Anticancer Agents Med Chem; 2020; 20(5):580-588. PubMed ID: 31994471
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and biological evaluation of novel 4-anlinoquinazoline derivatives as EGFR inhibitors with the potential to inhibit the gefitinib-resistant nonsmall cell lung cancers.
Wang C; Xu S; Peng L; Zhang B; Zhang H; Hu Y; Zheng P; Zhu W
J Enzyme Inhib Med Chem; 2019 Dec; 34(1):203-217. PubMed ID: 30835140
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological evaluation of 1-(benzofuran-3-yl)-4-(3,4,5-trimethoxyphenyl)-1H-1,2,3-triazole derivatives as tubulin polymerization inhibitors.
Qi ZY; Hao SY; Tian HZ; Bian HL; Hui L; Chen SW
Bioorg Chem; 2020 Jan; 94():103392. PubMed ID: 31669093
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis, and biological evaluation of novel substituted thiourea derivatives as potential anticancer agents for NSCLC by blocking K-Ras protein-effectors interactions.
Zhang Y; Meng X; Tang H; Cheng M; Yang F; Xu W
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):344-353. PubMed ID: 31851852
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis, and biological activity of a novel series of benzofuran derivatives against oestrogen receptor-dependent breast cancer cell lines.
Jin LP; Xie Q; Huang EF; Wang L; Zhang BQ; Hu JS; Wan DC; Jin Z; Hu C
Bioorg Chem; 2020 Jan; 95():103566. PubMed ID: 31935604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
